39736-29-3

Basic information

• Product Name: ETHYL 4-AMINO-2-(METHYLTHIO)-1,3-THIAZOLE-5-CARBOXYLATE
• Synonyms: SPECS AA-516/30012021;TIMTEC-BB SBB001485;AKOS 92826;ETHYL 4-AMINO-2-(METHYLTHIO)-1,3-THIAZOLE-5-CARBOXYLATE;ETHYL 4-AMINO-2-METHYLTHIOTHIAZOLE-5-CARBOXYLATE
• CAS NO: 39736-29-3
• Molecular Formula: C₇H₁₀N₂O₂S₂
• Molecular Weight: 218.3
• Product Categories: Building Blocks;Thiazole
• Mol File: 39736-29-3.mol
• Article Data: 13

Chemical Properties

• Melting Point: 100-102 °C(Solv: ethanol (64-17-5))
• Boiling Point: 368.6°Cat760mmHg
• Flash Point: 176.7°C
• Appearance: /
• Density: 1.37g/cm³
• Vapor Pressure: 1.26E-05mmHg at 25°C
• Refractive Index: 1.603
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 1.09±0.10(Predicted)
• CAS DataBase Reference: ETHYL 4-AMINO-2-(METHYLTHIO)-1,3-THIAZOLE-5-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-AMINO-2-(METHYLTHIO)-1,3-THIAZOLE-5-CARBOXYLATE(39736-29-3)
• EPA Substance Registry System: ETHYL 4-AMINO-2-(METHYLTHIO)-1,3-THIAZOLE-5-CARBOXYLATE(39736-29-3)

Safety Data

• Hazardous Substances Data: 39736-29-3(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Tetrahedron Letters, 7, p. 1885, 1966 DOI: 10.1016/0005-2760(66)90119-6

InChI:InChI=1/C7H10N2O2S2/c1-3-11-6(10)4-5(8)9-7(12-2)13-4/h3,8H2,1-2H3

Upstream product

• 623-51-8 ethyl 2-sulfanylacetate 
• 10191-60-3 dimethyl N-cyanodithioiminocarbonate 
• 10191-61-4 potassium S-methyl N-cyanocarbamodithioate 
• 105-36-2 ethyl bromoacetate 
• 10191-67-0 C₇H₁₀N₂O₂S₂ 
• 13145-41-0 potassium cyanocarbonimidodithioate 
• 74-88-4 methyl iodide 
• 105-39-5 chloroacetic acid ethyl ester 
• 10191-61-4 potassium methyl cyanoiminodithiocarbonate 
• 55919-47-6 ethyl 2-bromo-3-oxo-3-phenylpropionate 
• 84911-18-2 ethyl 2-bromoacetoacetate 

Downstream Products

• 1329991-68-5 C₁₄H₁₄ClN₃O₄S₂ 
• 1329991-69-6 C₁₄H₁₆ClN₃O₂S₂ 
• 1329991-71-0 C₁₈H₁₄ClN₃OS₂ 
• 1329991-72-1 C₁₈H₁₄ClN₃O₃S₂ 
• 1329991-73-2 C₁₄H₁₄ClN₃O₆S₂ 
• 1329991-74-3 C₁₃H₁₂ClN₃O₄S 
• 152300-59-9 ethyl 4-amino-1,3-thiazole-5-carboxylate 
• 1443014-87-6 ethyl 4-bromo-2-(methylsulfanyl)-1,3-thiazole-5-carboxylate 
• 147235-64-1 6-methylthio-2-(4-nitrophenyl)thiazolo<4,5-d><3,1>oxazin-4-one 
• 147235-60-7 2-(4-chlorophenyl)-6-methylthiothiazolo<4,5-d><3,1>oxazin-4-one 
• 147235-59-4 ethyl 2-methylthio-4-[(triphenylphosphanylidene)amino]thiazole-5-carboxylate 
• 94507-74-1 4-Amino-2-methylthiothiazole-5-carboxylic Acid 

Relevant articles and documents

Growth Factor Receptor antagonists. Preparation method and application thereof

The invention relates to a small molecule antagonist for transforming growth factor β receptors, a method for preparing the small molecule antagonist, and application of the small molecule antagonist in preparation of drugs. The small molecule antagonist for transforming the growth factor β receptor has the application of treating and/or preventing various diseases mediated by ALK5, and has great clinical application potential.

Synthesis method of ethyl 4-amino-2-(methylthio)thiazole-5-carboxylate

The invention belongs to the technical field of pharmaceutical intermediates, and relates to a synthesis method of ethyl 4-amino-2-(methylthio)thiazole-5-carboxylate. The method includes the followingsteps that an aqueous solution of cyanamide is mixed with ethanol, carbon disulfide and a potassium hydroxide solution are added for reaction, and a precipitated solid is subjected to suction filtration and drying to obtain an intermediate A; the intermediate A is dissolved in a mixed solution of ethanol and water, an iodomethane ethanol solution is dropped for reaction, and an intermediate B isobtained through concentration and drying; the intermediate B, ethyl chloroacetate and triethylamine are subjected to a reflux reaction in ethanol, and the obtained solution is concentrated, washed and re-crystallized to obtain ethyl 4-amino-2-(methylthio)thiazole-5-carboxylate. The cost of raw materials is low, the yield of by-products is low, the product yield is high, and the method is suitablefor scale-up production.

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.